RED BANK, NEW JERSEY / ACCESS Newswire / August 13, 2025 / Tharimmune, Inc. (Nasdaq:THAR) (“Tharimmune” or the “Company”), a clinical-stage biotechnology company dedicated to developing innovative ...

The alert follows a wave of warning letters the agency sent to Supergoop!, Vacation Inc. and three other popular brands, ...

A popular Aldi snack is facing a voluntary nationwide FDA recall. According to a recent FDA announcement, the Park Street ...

Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved ...

Net loss (GAAP) narrowed to $6.1 million in Q2 2025, a 22.8% improvement from the prior-year period, driven by reduced research and development spending. No product revenue reported; The company’s ...

Leadership and talent actions -- Lisa Wolf confirmed as CFO; key hires from Statera joined for regulatory, clinical, and ...

The Vicksburg Police Department is accepting applications for entry-level officer positions. The department said it offers a ...

The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...

MAXONA Pharmaceuticals has taken a key step toward advancing its flagship pain therapy, filing an Investigational New Drug ...

Researchers from Simon Fraser University have unveiled an artificial intelligence framework that could transform drug ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...

A new FDA program will use a two-phase approach to help boost domestic drug manufacturing, while OpenAI is leaning into health care with the launch of GPT-5.